74 related articles for article (PubMed ID: 27922666)
1. Noncoding RNAs that associate with YB-1 alter proliferation in prostate cancer cells.
Liu TT; Arango-Argoty G; Li Z; Lin Y; Kim SW; Dueck A; Ozsolak F; Monaghan AP; Meister G; DeFranco DB; John B
RNA; 2015 Jun; 21(6):1159-72. PubMed ID: 25904138
[TBL] [Abstract][Full Text] [Related]
2. Roles and Mechanisms of Human Cathelicidin LL-37 in Cancer.
Chen X; Zou X; Qi G; Tang Y; Guo Y; Si J; Liang L
Cell Physiol Biochem; 2018; 47(3):1060-1073. PubMed ID: 29843147
[TBL] [Abstract][Full Text] [Related]
3. Human antimicrobial peptides and cancer.
Jin G; Weinberg A
Semin Cell Dev Biol; 2019 Apr; 88():156-162. PubMed ID: 29694838
[TBL] [Abstract][Full Text] [Related]
4. Cathelicidin Antimicrobial Peptide Acts as a Tumor Suppressor in Hepatocellular Carcinoma.
Huang LH; Rau CS; Liu YW; Lin HP; Wu YC; Tsai CW; Chien PC; Wu CJ; Huang CY; Hsieh TM; Hsieh CH
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958632
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the antitumor activity of moronecidin (Piscidin)-like peptide in combination with anti-PD-1 antibody against melanoma tumor.
Mohammadi M; Moradi Hasan-Abad A; Ghasemi A
Iran J Basic Med Sci; 2023; 26(9):1061-1067. PubMed ID: 37605720
[TBL] [Abstract][Full Text] [Related]
6. LL-37 Might Promote Local Invasion of Melanoma by Activating Melanoma Cells and Tumor-Associated Macrophages.
Ohuchi K; Ikawa T; Amagai R; Takahashi T; Roh Y; Endo J; Kambayashi Y; Asano Y; Fujimura T
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980564
[TBL] [Abstract][Full Text] [Related]
7. Cathelicidin LL-37 promotes EMT, migration and metastasis of hepatocellular carcinoma cells in vitro and mouse model.
Zhang H; Yuan X; Yang Y; Wanyan Y; Tao L; Chen Y
Cell Adh Migr; 2023 Dec; 17(1):20-34. PubMed ID: 36656313
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma Cells.
Chernov AN; Filatenkova TA; Glushakov RI; Buntovskaya AS; Alaverdian DA; Tsapieva AN; Kim AV; Fedorov EV; Skliar SS; Matsko MV; Galimova ES; Shamova OV
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956937
[TBL] [Abstract][Full Text] [Related]
9. The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment.
Zhang Z; Chen WQ; Zhang SQ; Bai JX; Lau CL; Sze SC; Yung KK; Ko JK
Front Pharmacol; 2022; 13():906625. PubMed ID: 35935871
[TBL] [Abstract][Full Text] [Related]
10. YB-1 as an Oncoprotein: Functions, Regulation, Post-Translational Modifications, and Targeted Therapy.
Yin Q; Zheng M; Luo Q; Jiang D; Zhang H; Chen C
Cells; 2022 Apr; 11(7):. PubMed ID: 35406781
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial peptides: mechanism of action, activity and clinical potential.
Zhang QY; Yan ZB; Meng YM; Hong XY; Shao G; Ma JJ; Cheng XR; Liu J; Kang J; Fu CY
Mil Med Res; 2021 Sep; 8(1):48. PubMed ID: 34496967
[TBL] [Abstract][Full Text] [Related]
12. YB-1 Is Altered in Pregnancy-Associated Disorders and Affects Trophoblast in Vitro Properties via Alternation of Multiple Molecular Traits.
Stojanovska V; Shah A; Woidacki K; Fischer F; Bauer M; Lindquist JA; Mertens PR; Zenclussen AC
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281280
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance.
Alkrekshi A; Wang W; Rana PS; Markovic V; Sossey-Alaoui K
Cell Signal; 2021 Sep; 85():110073. PubMed ID: 34224843
[TBL] [Abstract][Full Text] [Related]
14. Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma.
Johnson TG; Schelch K; Mehta S; Burgess A; Reid G
Front Cell Dev Biol; 2019; 7():221. PubMed ID: 31632972
[TBL] [Abstract][Full Text] [Related]
15. Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN.
Shimizu K; Yamasaki S; Sakurai M; Yumoto N; Ikeda M; Mishima-Tsumagari C; Kukimoto-Niino M; Watanabe T; Kawamura M; Shirouzu M; Fujii SI
Front Immunol; 2019; 10():1450. PubMed ID: 31293597
[TBL] [Abstract][Full Text] [Related]
16. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling.
Ji P; Zhou Y; Yang Y; Wu J; Zhou H; Quan W; Sun J; Yao Y; Shang A; Gu C; Zeng B; Firrman J; Xiao W; Bals R; Sun Z; Li D
Theranostics; 2019; 9(8):2209-2223. PubMed ID: 31149039
[No Abstract] [Full Text] [Related]
17. Translating Nanomedicine to Comparative Oncology-the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic Cancer.
DeLong RK; Cheng YH; Pearson P; Lin Z; Coffee C; Mathew EN; Hoffman A; Wouda RM; Higginbotham ML
J Pharmacol Exp Ther; 2019 Sep; 370(3):671-681. PubMed ID: 31040175
[TBL] [Abstract][Full Text] [Related]
18. miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.
Lin Z; Lu Y; Meng Q; Wang C; Li X; Yang Y; Xin X; Zheng Q; Xu J; Gui X; Li T; Pu H; Xiong W; Li J; Jia S; Lu D
Mol Ther Nucleic Acids; 2018 Jun; 11():494-507. PubMed ID: 29858084
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells.
Jia J; Zheng Y; Wang W; Shao Y; Li Z; Wang Q; Wang Y; Yan H
Mol Med Rep; 2017 Jan; 15(1):240-248. PubMed ID: 27922666
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
